Immix Biopharma, Inc.
USD10.68
+0.19 (+1.84%)
CEO
Ilya Rachman
IPO Date
2021-12-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$10.47
Prev. Close
$10.49
Day Low
$10.36
Day High
$10.73
52W Low
$1.94
52W High
$11.61
Market Cap
$0.58B
Volume
0.69M
| -2.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -94.0% | -77.4% | 0.00 | 5.32 | -7.8 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -62.5% | -55.2% | 0.00 | 11.70 | -3.9 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -135.5% | -134.0% | 0.00 | 90.01 | -0.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 24.3% | -212.7% | -0.87 | 0.10 | -24.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 26.7% | -103.2% | -1.12 | 0.20 | -12.7 |
| -4.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -91.8% | -37.8% | 0.13 | 1.53 | -2.2 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -142.3% | -42.4% | 0.22 | 1.23 | -2.3 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -47.3% | -22.8% | 0.11 | 1.80 | -2.7 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -36.3% | -21.0% | 0.08 | 2.33 | -3.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -40.7% | -28.4% | 0.06 | 3.47 | -1.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -18.4% | -15.2% | 0.05 | 7.00 | -3.5 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -18.8% | -15.3% | 0.04 | 5.82 | -3.3 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -31.0% | -25.5% | 0.00 | 5.32 | -6.8 |